Haemonetics' Fiscal Q1 Adjusted Earnings, Net Revenue Increase; Fiscal 2027 Outlook Raised
MT Newswires Live
Aug 06
Haemonetics (HAE) reported fiscal Q1 adjusted earnings Thursday of $1.14 per diluted share, up from $1.10 a year earlier.
Analysts polled by FactSet expected $0.87.
Net revenue for the quarter ended June 27 was $339.4 million, compared with $321.4 million a year earlier.
Analysts expected $327.9 million.
The company raised its fiscal 2027 outlook and now expects 5% to 8% growth in both revenue and adjusted EPS, from 4% to 7% previously. Analysts expect adjusted EPS of $4.50 on revenue of $1.40 billion.
Shares of Haemonetics were down more than 1% premarket Thursday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.